期刊文献+

慢性盆腔炎性不孕患者体内子宫内膜整合素αVβ3表达

下载PDF
导出
摘要 盆腔炎不孕占不孕冈素的30%~40%,虽慢性盆腔炎所致不孕与病原菌感染有关,但并非生殖道感染均导致不孕。
出处 《浙江医学》 CAS 2011年第12期1823-1825,共3页 Zhejiang Medical Journal
  • 相关文献

参考文献9

  • 1卢如玲,李莉.慢性盆腔炎的证治研究[J].现代中西医结合杂志,2007,16(33):5069-5070. 被引量:2
  • 2Garcia P A,Nieto M A.Expression of αV,α4,α5 and β3 integrin subunits,fibronectin and vitronectin in goat peri-implantation[J].Science,2004,80(5):91-100.
  • 3Bumett C A,Xie J,Quijano J,et al.Synthesis in vitro,and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor[J].Bioorg Med Chem,2005,13:3763-3771.
  • 4Ricardo F S,AJosé L P.Expression of alpha 1 and beta 3 integrins subunits in the endometrium of patients with tubal phimosis or hydrosalpinx[J].Reproductive biology,2006,85(1):189-192.
  • 5Skrzypczak J M,Mikolajczyk,Szymanowski.Endometrial receptivity:Expression ofα3β1,α4β1,αvβ1 endometrial integrins in women with impared fertility[J].Biological Reproduction,2011,2:85-94.
  • 6Tei C T,Maruyama N Kuji T,et al.Reduced expression of αⅴ、β3 integin in the endometrium of unexplained infertility patients with recurrent IVF-ET failures:Improvement by danazol treatment[J].Journal of Assisted Reproduction and Genetics,2003,20(2):13-20.
  • 7张石革.整合素受体阻断剂的进展与临床评价[J].中国医院用药评价与分析,2011,11(10):872-875. 被引量:4
  • 8Ceydeli N S,Kaleli Z,Calay C T.Difference in av β3 integrin expression in endometrial stromal cell in subgroups of women with unexplained infertility[J].European Journal of Obstrics Gynecology and Reproductive Biology,2010,126(2):206-211.
  • 9Thomas K.Endometrial integrins expression in women undergoing in vitro fertilization and the association with subsesquent treatment outcome[J].Fertil Steril,2003,80(3):502-507.

二级参考文献42

  • 1姚石安,姚寓晨.妇友冲剂对慢性盆腔炎患者血液流变学的影响[J].国医论坛,1993,8(4):40-41. 被引量:8
  • 2徐东琴,吴高媛,黄河玲,傅汝廉,开桂云.益肾活血汤加CO_2激光照射治疗实验性大鼠慢性子宫内膜炎的疗效观察[J].天津中医,1993,10(4):33-34. 被引量:2
  • 3高慧.中药盆炎康胶囊治疗慢性盆腔炎的临床研究[J].承德医学院学报,1996,13(4):304-309. 被引量:4
  • 4芦冬梅 林宾华.益气祛瘀汤并灌肠治疗慢性盆腔炎40例[J].辽宁中医杂志,2000,27(8):358-358.
  • 5Van Dellen D,Tiivas CA,Jarvi K,et al. Transcranial Doppler uhrasonography-directed intranenoous glyeoprotein Ⅱ b/Ⅲ areceptor antagonist therapy to control transient cerebral microemboli before and after carotid endartereetomy[ J ]. Br J Surg ,2008 ,95 ( 6 ) :709.
  • 6Danzi GB, Capuano C, Sesana M, et al. Variability in extent of platelet function inhibition after administration of optimal dose of glycoprotein Ⅱ/bⅢ receptor blockers in patients undergoing a high-risk percutaneous coronary intervention [ J ]. Am J Cardiol,2006,97 (4) :489.
  • 7Bolognese L, Falsini G, Liistro F, et al. Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions : the EVEREST trial[J]. J Am Coll Cardiol,2006 ,47 ( 3 ) :522.
  • 8Danzi GB, Sesana M, Capuano C, et al. Downstream administration of a high-dose tirofiban bolus in high-risk patients with unstable angina undergoing early percutaneous coronary intervention [ J ]. Int J Cardiol , 2006,107 (2) :241.
  • 9Roffi M ,Chew DP, Mukherjee D,et al. Platelet glycoprotein Ⅱ b/Ⅲ inhibitors reduce mortality in diabetic patients with non-ST-segment elevation acute coronary syndromes [ J ]. Circulation,2001,104(23) :2767.
  • 10Summers KM, Holdford DA, Crouch MA. Cost-effectiveness analysis of antithrombotic therapy in nonurgent percutaneous coronary intervention [ J ]. Pharmacotherapy , 2006,26 ( 5 ) : 609.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部